These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1981538)

  • 1. Metabolism and disposition of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in conscious monkeys after subsequent i.v. oral, and ocular administration.
    Gerding TK; Drenth BF; de Zeeuw RA; Tepper PG; Horn AS
    Drug Metab Dispos; 1990; 18(6):923-8. PubMed ID: 1981538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration. I. Disposition and metabolic profiling.
    Gerding TK; Drenth BF; Roosenstein HJ; de Zeeuw RA; Tepper PG; Horn AS
    Xenobiotica; 1990 May; 20(5):515-24. PubMed ID: 1971983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration. II. Isolation and identification of metabolites.
    Gerding TK; Drenth BF; de Zeeuw RA; Tepper PG; Horn AS
    Xenobiotica; 1990 May; 20(5):525-36. PubMed ID: 1971984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular and systemic disposition of the dopamine agonist N-0437 in monkeys after ocular administration.
    Gerding TK; Drenth BF; de Zeeuw RA; Horn AS; van Delft JL; Oosterhuis JA
    Exp Eye Res; 1990 Jul; 51(1):11-4. PubMed ID: 1973654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the dopamine D2 agonist S(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in freely moving rats.
    Swart PJ; de Zeeuw RA
    J Pharm Sci; 1993 Feb; 82(2):200-3. PubMed ID: 8095299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
    Manzione BM; Bernstein JR; Franklin RB
    Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
    Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
    Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the dopamine D2 agonist N-0923 and its major metabolites in perfused rat livers by HPLC-UV-atmospheric pressure ionization mass spectrometry.
    Swart PJ; Oelen WE; Bruins AP; Tepper PG; de Zeeuw RA
    J Anal Toxicol; 1994; 18(2):71-7. PubMed ID: 7911536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
    Mamidi RN; Cuyckens F; Chen J; Scheers E; Kalamaridis D; Lin R; Silva J; Sha S; Evans DC; Kelley MF; Devineni D; Johnson MD; Lim HK
    Drug Metab Dispos; 2014 May; 42(5):903-16. PubMed ID: 24568888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man.
    Battaglia R; Strolin Benedetti M; Mantegani S; Castelli MG; Cocchiara G; Dostert P
    Xenobiotica; 1993 Dec; 23(12):1377-89. PubMed ID: 7907829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion and biotransformation of cisapride in rats after oral administration.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
    Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal delivery.
    Cawello W; Braun M; Boekens H
    Drug Metab Dispos; 2009 Oct; 37(10):2055-60. PubMed ID: 19608695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, disposition, and metabolism of bicifadine in the mouse, rat, and monkey.
    Musick TJ; Gohdes M; Duffy A; Erickson DA; Krieter PA
    Drug Metab Dispos; 2008 Feb; 36(2):241-51. PubMed ID: 17991767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.